Infectious Diseases News and Research

RSS

Correcting flaws in the Ebola response

How hospital and health workers react to suspected cases of Ebola going forward is the subject of much scrutiny. But, even as public health and many elected officials urge calm, some potential 2016 presidential candidates say President Obama isn't doing enough to keep the disease out of the U.S.

6 Oct 2014

Canada announces deployment of second mobile lab team to West Africa

The Honourable Rona Ambrose, Minister of Health, with Canada's Chief Public Health Officer Dr. Gregory Taylor, announced the deployment of a second mobile lab team to West Africa.

6 Oct 2014

Scientists shed new light on how LAMR1 and Gal-3 proteins can cause meningitis, septicaemia

Previously undiscovered secrets of how human cells interact with a bacterium which causes a serious human disease have been revealed in new research by microbiologists at The University of Nottingham.

5 Oct 2014

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Surveying patients with traumatic brain injuries, a group of Los Angeles Biomedical Research Institute researchers reported today that they found those who tested positive for THC, the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance.

3 Oct 2014

Blackflies infected with Onchocerca volvulus parasite may spread nodding syndrome

Despite decades of research, scientists have yet to pinpoint the exact cause of nodding syndrome (NS), a disabling disease affecting African children. A new report suggests that blackflies infected with the parasite Onchocerca volvulus may be capable of passing on a secondary pathogen that is to blame for the spread of the disease. New research is presented in the International Journal of Infectious Diseases.

3 Oct 2014

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Diet-induced changes in the gut's bacterial ecosystem can alter susceptibility to an autoinflammatory bone disease by modifying the immune response, St. Jude Children's Research Hospital scientists reported. The findings appeared September 28 as an advanced online publication of the scientific journal Nature.

3 Oct 2014

Animal study suggests ibuprofen can reduce lung inflammation in elderly

New research shows that the lungs become more inflammatory with age and that ibuprofen can lower that inflammation.

3 Oct 2014

Cepheid to acquire LABSCO's customer relationships for $21M

Cepheid today announced that, effective today, it has entered into a purchase agreement to acquire the customer relationships from its former distribution partner, the Laboratory Supply Company (LABSCO).

3 Oct 2014

Family physician answers questions related to Ebola virus

According to the Centers for Disease Control, the outbreak of Ebola in four West African countries is one of the largest outbreaks of the disease in history.

1 Oct 2014

Salk researchers receive BRAIN Initiative funding

Joseph Ecker, a Salk professor and Howard Hughes Medical Institute investigator, and Margarita Behrens, Salk staff scientist, have been named recipients in the 2014 round of grants from the National Institutes of Health (NIH) through the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative for leading-edge work in neuroscience.

1 Oct 2014

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.

30 Sep 2014

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Johnson & Johnson today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

30 Sep 2014

Luminex gets FDA approval to add three new targets to xTAG Gastrointestinal Pathogen Panel

Luminex Corporation today announced it has received U.S. FDA clearance to add three new targets to its xTAG Gastrointestinal Pathogen Panel (GPP). The targets include Adenovirus 40/41, Entamoeba histolytica and Vibrio cholerae.

From Luminex 30 Sep 2014

Research finding opens door to potential treatment for MPS IIIB

MPS IIIB is a devastating and currently untreatable disease that causes progressive damage to the brain, leading to profound intellectual disability, dementia and death -- often before reaching adulthood.

30 Sep 2014

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).

30 Sep 2014

Seven NIH research contracts awarded to identify novel adjuvant candidates

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability.

30 Sep 2014

New report urges nations to adopt improved data collection efforts for community health workers

A new report finds that developing nations' ability to deal with pressing health challenges like HIV/AIDS and ensuring maternal and newborn survival will be strengthened by creating a common definition for community health workers, as well as a core set of skills and competencies that would help ensure they are optimally trained, supported and deployed to provide care and treatment when and where it is needed most.

29 Sep 2014

Infectious Diseases News and Research

Correcting flaws in the Ebola response

Canada announces deployment of second mobile lab team to West Africa

Scientists shed new light on how LAMR1 and Gal-3 proteins can cause meningitis, septicaemia

LA BioMed researchers report that THC may help protect the brain of traumatic brain injury patients

Blackflies infected with Onchocerca volvulus parasite may spread nodding syndrome

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Animal study suggests ibuprofen can reduce lung inflammation in elderly

Cepheid to acquire LABSCO's customer relationships for $21M

Family physician answers questions related to Ebola virus

Salk researchers receive BRAIN Initiative funding

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Luminex gets FDA approval to add three new targets to xTAG Gastrointestinal Pathogen Panel

Research finding opens door to potential treatment for MPS IIIB

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Seven NIH research contracts awarded to identify novel adjuvant candidates

New report urges nations to adopt improved data collection efforts for community health workers

Canadian government committed to prevent, detect, and respond to infectious disease outbreaks

Australian researchers use hookworms to reduce symptoms of celiac disease

CDC forecast: Ebola epidemic could infect more than 1.4 million people by January end

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News